Lyophilization: how freeze-drying preserves peptides

Almost every research peptide arrives the same way: a small white cake or powder at the bottom of a sealed vial. That powder started as a liquid. It was turned into a dry solid by lyophilization, or freeze-drying, one of the most widely used preservation methods in pharmaceutical and biochemical manufacturing. This article explains how the process works and why it's used for peptides.

What lyophilization is

Lyophilization removes water from a frozen product by sublimation: the direct change from solid ice to water vapor, skipping the liquid phase entirely.

A useful comparison is dry ice, which turns straight from solid to gas at normal pressure. Under a deep enough vacuum, ordinary ice does the same. Freeze-drying uses that to pull water out of a sample while it stays frozen.

The name comes from Greek roots meaning roughly "solvent-loving", a reference to how readily a well freeze-dried product takes up water again. The technique has been used in manufacturing for decades for vaccines, antibiotics, enzymes and peptides.

The three phases

Freeze-drying is not simply "freeze it and pull a vacuum". It runs in three controlled phases, and each one affects the quality of the final cake.

1. Freezing

The peptide solution is cooled well below freezing, commonly to around −40 °C or lower. Industrial freeze-dryers cool at a controlled rate, because the rate decides the size of the ice crystals that form.

Crystal size matters. Larger crystals leave larger pores in the finished cake. But freezing too slowly lets peptide molecules concentrate in the shrinking pockets of liquid between crystals, which can encourage aggregation. The freezing step is tuned for each product to balance the two.

2. Primary drying (sublimation)

Next the chamber is brought down to a deep vacuum, a tiny fraction of normal atmospheric pressure. At that pressure the ice doesn't melt; it sublimates straight to vapor, which is collected on a very cold condenser.

The shelves holding the vials are warmed just enough to supply the heat sublimation needs, without letting the product warm past its collapse temperature, the point at which the frozen structure softens and loses its shape. Primary drying removes most of the water and is the longest phase, often running a day or more.

3. Secondary drying (desorption)

Once the ice is gone, some water is still bound to the surfaces of the peptide and other solids. In secondary drying the shelf temperature is raised while the vacuum is held, driving off that bound water.

The goal is a low, controlled residual moisture. Too much water left behind lets degradation reactions continue slowly in the dry cake. Drying too hard can stress some molecules. Manufacturers set a target range for each product.

Why freeze-drying suits peptides

Other ways of drying a solution are harsher on delicate molecules:

• Evaporative drying means heating the liquid. The peptide spends time in a warm, increasingly concentrated solution, and at the air-liquid surface, both of which can change its structure.
• Spray drying atomizes the solution into hot gas. It's fast, but it exposes the material to high temperatures that many peptides don't tolerate well.

In lyophilization the peptide is frozen solid before drying begins, and the water leaves as vapor from a solid matrix. The peptide avoids high heat and prolonged time in solution. That's why freeze-drying is the standard choice for peptides and many other biomolecules.

Dry versus liquid stability

Water drives most of the chemical reactions that break peptides down, including hydrolysis of peptide bonds, deamidation of asparagine and glutamine, and some oxidation pathways. In solution those reactions can proceed over days or weeks, faster at higher temperatures. Take the water away and they slow to a crawl.

That's the reason research peptides are shipped and stored as a dry powder. As general guidance, a properly lyophilized peptide in a sealed vial holds up far longer than the same peptide in solution:

These are general figures, and real stability varies by compound. Sequence matters: peptides containing methionine or cysteine are more prone to oxidation, and those rich in asparagine deamidate more readily. Where compound-specific storage data exists, it takes priority.

Excipients: what else may be in the vial

Some freeze-dried products contain more than the active compound. Inactive ingredients called excipients can help the process:

• Bulking agents such as mannitol or glycine give the cake physical structure when the amount of peptide is very small.
• Cryoprotectants such as sucrose or trehalose help stabilize molecules during freezing and drying.
• Buffers hold pH steady. Some buffer salts crystallize during freezing and shift pH, so the choice of buffer matters.

Many research peptides are supplied as the peptide and its counter-ion alone. A certificate of analysis or product specification will show what the material is.

What a sealed vial can tell you

The appearance of the cake reflects how well the process went. Before a vial is ever opened, you can look for:

• A uniform, porous cake or powder, white to off-white. A cake that has broken into loose powder in transit is normal.
• No discoloration. Yellowing, browning or dark spots can indicate degradation.
• No collapse or meltback. A shrunken, glassy or sticky mass suggests the product warmed past its collapse temperature during drying.
• No visible moisture or condensation inside the vial.

Appearance is a quick first check, not a measurement. Purity and identity can only be confirmed by analytical testing, which is what a certificate of analysis reports.

In short

• Lyophilization removes water by sublimation, from a frozen sample under vacuum.
• It runs in three phases: freezing, primary drying and secondary drying.
• It avoids the heat and liquid-phase stress of other drying methods.
• A dry, sealed peptide is far more stable than one in solution, especially when kept cold and dark.

For how to keep sealed vials in good condition once they arrive, see our guide to storing sealed vials.

All products are sold for laboratory research use only and are not for human or veterinary use.